N/A N=94 The STEP 4Life Trial
Alzheimer Disease, At Risk · Alzheimer Disease, Protection Against · Dementia
Primary: Change in Mean Daily Steps From the Baseline Period to the End of the 12 Week Intervention Period. — 735; 2422 steps
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=48 Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device
Wrinkle · Benign Pigmented Lesions · Benign Vascular Lesions
Primary: Number of Subjects Who Noticed Improvement — 10; 34 Participants
N/A N=24 Pregnancy Intervention With a Closed-Loop System (PICLS) Study
Type 1 Diabetes Mellitus · Pregnancy in Diabetes
Primary: Number of Episodes of Severe Hypoglycemia — 0; 0 Number of Episodes
N/A N=32 Adaptive CRT Effect on Electrical Dyssynchrony
Cardiomyopathy · Heart Failure · Left Bundle Branch Block
Primary: Change in Ventricular Electrical Uncoupling (VEU), Calculated as the Difference in Difference Between the Mean Left Ventricular (LV) and Right Ventricular (RV)…
N/A N=20 A Study of Atherosclerosis in Patients After Radiation Treatment for Breast Cancer
Atherosclerosis
Primary: Number of Participants Analyzed for Coronary Calcium Burden by AGS — 9; 11 Participants
N/A N=113 Virtual Reality Distraction for Reduction
Postoperative Pain
Primary: Pain Scores (Numerical Rating Scale) — 3.4; 3.5 score on a scale — p=0.391
N/A N=30 Sound Check-Correlation Between Transperineal and Digital Cervical Exam in 3rd Trimester Pregnancy
Cervix; Pregnancy
Primary: Correlation of Cervical Dilation Via Butterfly iQ Pocket Ultrasound in Centimeters — 5.1; 5 centimeters — p=.0001
Phase 1 N=36 A Safety Study of AZD4041 in Healthy Participants
Opioid Use Disorder (OUD)
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs) — 8; 6; 6; 9 Participants
Phase 2 N=118 Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Metastatic Breast Carcinoma · Stage IIIB Breast Cancer AJCC v7 · Stage IIIC Breast Cancer AJCC v7
Primary: Number of Participants With Progression Free Survival (PFS) at 12 Months — 8; 16 Participants
N/A N=54 Post Marketing Study to Evaluate the NIMBUS Device
Cerebral Stroke
Primary: Percentage of Participants With Successful Revascularization With NIMBUS Device — 68.6 Percentage of participants
N/A N=4,733 Test to Stay in School: COVID-19 Testing Following Exposure in School Communities
Covid19
Primary: Number of Students With Positive COVID-19 Test Following Known Within-school Exposure. — 285 Participants
N/A N=89 Mindfulness and Mechanisms of Pain Processing in Adults With Migraines
Migraine
Primary: Change in Frequency of Migraine Days Per Month From Baseline — -1.6; -2.0 number of days
Phase 1 N=26 Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
B-cell Malignancies
Primary: Arm A: Area Under Plasma Concentration-time Curve up to the Last Measurable Concentration (AUC0-t) — 1899.32; 921.63; 797.87 h*ng/mL
Early Phase 1 N=8 Oxytocin on HR in Sleep Apnea Patient
Sleep Apnea
Primary: Frequency of Hypopnea Events — 8.5 Incidence of hypopnea events
Phase 3 N=31 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea
Diarrhea, Infantile
Primary: Duration of Diarrhea (Hours) Between the Start of Treatment Until Last Diarrheal/Watery Stool Before Recovery or End of Study Treatment (Treatment Duration Maximal 5…